科学家发现了一种出人意料的平复焦虑心灵的方法

* *Draft:* 在加州大学旧金山分校 (UCSF)，神经科学家 Jennifer Mitchell 博士正在领导研究针对焦虑、抑郁、创伤后应激障碍 (PTSD)、冲动、压力和成瘾等疾病的创新疗法。 * *Refinement:* "PTSD" is often translated as 创伤后应激障碍. "Impulsivity" -> 冲动行为 or 冲动. "Addiction" -> 成瘾. * *Para 1 (cont.):* "She believes a new approach could help where standard therapies fall short -- and early results are encouraging." * *Draft:* 她认为一种新方法可以在标准疗法不足之处发挥作用——而且早期结果是令人鼓舞的。 * *Refinement:* "Fall short" -> 效果不佳/存在局限. "Encouraging" -> 令人振奋/令人鼓舞. * *Para 2:* "This potential breakthrough treatment? A carefully developed pharmaceutical form of LSD." * *Draft:* 这种潜在的突破性疗法是什么？一种精心研发的药物形式的 LSD。 * *Refinement:* "Pharmaceutical form" -> 药物制剂形式/药物形式. LSD -> 麦角酸二乙酰胺 (usually keep LSD or use the full name once, but in this context, keeping LSD is standard in scientific reporting, or use "LSD 药物制剂"). Let's stick to "LSD 的药物制剂形式". * *Para 3:* "What is generalized anxiety disorder?" * *Draft:* 什么是广泛性焦虑障碍？ * *Para 4:* "Generalized anxiety disorder is a persistent and excessive form of anxiety that feels out of proportion to actual events or situations. It interferes with daily functioning, affecting relationships, work, and overall quality of life." * *Draft:* 广泛性焦虑障碍是一种持续且过度的焦虑形式，其程度与实际事件或情况不成比例。它干扰日常功能，影响人际关系、工作和整体生活质量。 * *Refinement:* "Out of proportion" -> 不成比例. * *Para 5:* "People living with GAD may struggle to focus, make decisions, or remember information, making it difficult to manage responsibilities at work or home." * *Draft:* 广泛性焦虑障碍 (GAD) 患者可能难以集中注意力、做出决定或记住信息，这使得管理工作或家庭责任变得困难。 * *Refinement:* "People living with GAD" -> GAD 患者. * *Para 5 (cont.):* "The condition can also lead to fatigue, irritability, and secondary depression. Many individuals hesitate to leave their homes for fear of feeling trapped, embarrassed, or helpless in social or public settings." * *Draft:* 这种情况还会导致疲劳、易怒和继发性抑郁。许多人因为害怕在社交或公共场所感到被困住、尴尬或无助而不愿离开家。 * *Refinement:* "Secondary depression" -> 继发性抑郁. "Hesitate to leave" -> 犹豫不愿离开/不敢离开. * *Para 6:* "How is it different from day-to-day anxiety?" * *Draft:* 它与日常焦虑有何不同？ * *Para 7:* "A hallmark of generalized anxiety disorder is that it manifests as physical symptoms." * *Draft:* 广泛性焦虑障碍的一个显著特征是它表现为身体症状。 * *Refinement:* "Hallmark" -> 标志/显著特征. "Manifests as" -> 表现为. * *Para 7 (cont.):* "Persistent worry activates the body's fight-or-flight response, triggering stress hormones that cause physical effects." * *Draft:* 持续的担忧会激活身体的“战斗或逃跑”反应，触发压力荷尔蒙，从而导致生理效应。 * *Refinement:* "Fight-or-flight" -> 战斗或逃跑. "Stress hormones" -> 应激激素/压力荷尔蒙. "Physical effects" -> 生理影响/身体效应. * *Para 7 (cont.):* "Patients may have muscle tension and rapid breathing, and report symptoms like headaches and insomnia, ringing in the ears, and cardiovascular, respiratory, and gastrointestinal issues." * *Draft:* 患者可能出现肌肉紧张和呼吸急促，并报告头痛、失眠、耳鸣以及心血管、呼吸和胃肠道问题等症状。 * *Refinement:* "Ringing in the ears" -> 耳鸣. "Cardiovascular..." -> 心血管、呼吸系统和胃肠道问题. * *Para 8:* "How is generalized anxiety disorder treated?" * *Draft:* 广泛性焦虑障碍如何治疗？ * *Para 9:* "It's usually treated with medications like Zoloft and Paxil that boost and stabilize the neurotransmitter serotonin, leading to reduced anxiety and enhanced emotional well-being." * *Draft:* 通常使用如 Zoloft 和 Paxil 等药物进行治疗，这些药物能增强并稳定神经递质血清素，从而减轻焦虑并增强情绪健康。 * *Refinement:* Zoloft (舍曲林), Paxil (帕罗西汀). I should probably include the generic names or keep brand names if standard. Usually, in translation, keeping brand names is okay, but adding generic names is better for clarity. Let's keep brand names as per source but maybe add generic names in brackets for professionalism? The prompt asks to retain scientific details. Brand names are specific. I will translate the sentence structure. "Neurotransmitter serotonin" -> 神经递质血清素 (or 5-羟色胺). Serotonin is usually translated as 血清素 or 5-羟色胺. I will use 血清素. * *Para 9 (cont.):* "These medications have been found to reduce symptoms by an average of 1.25 points on the 56-point anxiety scale -- insufficient to make significant difference for at least some patients." * *Draft:* 研究发现，这些药物在 56 分制的焦虑量表上平均能减少 1.25 分的症状——这不足以对至少部分患者产生显著影响。 * *Refinement:* "56-point anxiety scale" -> 56 分制焦虑量表. "Significant difference" -> 显著差异. * *Para 10:* "Why LSD?" * *Draft:* 为什么选择 LSD？ * *Para 11:* "LSD as well as other psychedelics, have tremendous potential to shift mood and emotions when used in a controlled, therapeutic setting. We have seen this in a previous trial of Ecstasy to treat PTSD." * *Draft:* LSD 以及其他致幻剂（迷幻药），在受控的治疗环境中使用时，具有改变情绪和情感的巨大潜力。我们在之前使用 Ecstasy 治疗 PTSD 的试验中已经看到了这一点。 * *Refinement:* "Psychedelics" -> 致幻剂/迷幻药. In scientific context, "致幻剂" is formal. "Ecstasy" -> 在这项发表于《美国医学会杂志》（JAMA）的早期研究阶段中，研究人员在约200名患有中重度广泛性焦虑症的参与者中，评估了单剂量MM120在12周内的疗效。该药物显著缓解了症状，在扣除安慰剂效应后，焦虑量表评分降低了5到6分。这一效果相当显著，在某些情况下足以将中度广泛性焦虑症重新归类为轻度。 **是否有副作用？** 给药后，医务人员对参与者进行了仔细监测。副作用通常为轻度或中度，包括幻觉、视觉扭曲、恶心和头痛。值得注意的是，这些副作用在使用最高剂量时更为普遍——我们将不会使用该剂量，因为研究发现其疗效并未更佳。恶心是致幻剂的常见副作用，但通过限制参与者进食清淡早餐并预先给予止吐药，这一症状得到了缓解。 **在招募研究参与者方面，你们面临哪些挑战？** 我们寻找的是患有中重度广泛性焦虑症的人群，通常是那些症状严重导致功能受损且不愿离家的人。具有讽刺意味的是，最符合资格的人往往最不可能现身。参与者由经验丰富的临床医生进行筛查，医生会通过询问、观察肢体语言，并细心建立融洽关系。我们希望以此建立信任，使参与者能够敞开心扉并进行反思。